{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:36:04Z","timestamp":1793385364567,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jacadv.2024.100991","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T01:00:00Z","timestamp":1716512400000},"page":"100991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P1","title":["Characteristics and Management of\u00a0Patients With Cancer and Atrial\u00a0Fibrillation"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-7125","authenticated-orcid":false,"given":"Michele Massimo","family":"Gulizia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Maria","family":"Turazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-7287","authenticated-orcid":false,"given":"Pietro","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Alings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-1272","authenticated-orcid":false,"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donata","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Parrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto J.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furio","family":"Colivicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2024.100991_bib1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1186\/s12885-019-6314-9","article-title":"Incidence of atrial fibrillation in different major cancer subtypes: a nationwide population-based 12 year follow up study","volume":"19","author":"Jakobsen","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jacadv.2024.100991_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pcad.2021.04.004","article-title":"Cancer and atrial fibrillation: epidemiology, mechanisms, and anticoagulation treatment","volume":"66","author":"Menichelli","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacadv.2024.100991_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ehjqcco\/qcy040","article-title":"Efficacy and safety of rivaroxaban vs warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF","volume":"5","author":"Chen","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacadv.2024.100991_bib4","article-title":"Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: analysis of the ENGAGE AF - TIMI 48 trial","volume":"7","author":"Fanola","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2024.100991_bib5","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/cncr.33470","article-title":"Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study","volume":"127","author":"Pastori","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jacadv.2024.100991_bib6","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jacc.2019.01.017","article-title":"Anticoagulation strategies in patients with cancer: JACC review topic of the week","volume":"73","author":"Mosarla","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.100991_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0039-3400300","article-title":"Efficacy and safety of nonvitamin K oral anticoagulants in patients with atrial fibrillation and cancer: a study-level meta-analysis","volume":"120","author":"Cavallari","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacadv.2024.100991_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/bloodadvances.2017010694","article-title":"Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation","volume":"2","author":"Shah","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jacadv.2024.100991_bib9","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2018.07.077","article-title":"Provider specialty, anticoagulation, and stroke risk in patients with atrial fibrillation and cancer","volume":"72","author":"O'Neal","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.100991_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejim.2018.10.012","article-title":"Atrial fibrillation in patients with active malignancy and use of anticoagulants: under-prescription but no adverse impact on all-cause mortality","volume":"59","author":"Malavasi","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacadv.2024.100991_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejim.2020.08.004","article-title":"Patterns of anticoagulation for atrial fibrillation in cancer patients referred to cardio-oncological evaluation","volume":"82","author":"Toma","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacadv.2024.100991_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2024.100991_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaccao.2020.09.008","article-title":"Pattern of anticoagulation use in patients with cancer with atrial fibrillation and\/or atrial flutter","volume":"2","author":"Fradley","year":"2020","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jacadv.2024.100991_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/europace\/euy166","article-title":"Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ-AF study","volume":"21","author":"Gulizia","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacadv.2024.100991_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2024.100991_bib16","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.amjcard.2015.01.540","article-title":"Relation between cancer and atrial fibrillation (from the REasons for geographic and racial differences in stroke study)","volume":"115","author":"O'Neal","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacadv.2024.100991_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban vs warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.100991_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/phar.2679","article-title":"Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016","volume":"42","author":"Ardeshirrouhanifard","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacadv.2024.100991_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bjh.18060","article-title":"Oral anti-coagulant treatment patterns in atrial fibrillation patients diagnosed with cancer: a Danish nationwide cohort study","volume":"197","author":"Ording","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacadv.2024.100991_bib20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.amjmed.2017.06.026","article-title":"Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE trial","volume":"130","author":"Melloni","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jacadv.2024.100991_bib21","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban vs warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.100991_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Hokusai VTE cancer investigators. Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N\u00a0Engl J Med"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24001790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24001790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:29:54Z","timestamp":1722158994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X24001790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2772963X24001790"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.100991","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and Management of\u00a0Patients With Cancer and Atrial\u00a0Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.100991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100991"}}